Open Access

Practical issues for use of oral factor Xa inhibition in patients with acute pulmonary embolism and deep vein thrombosis.

Congress Presentation

About the speaker

Professor Ajay Kakkar

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

4 more presentations in this session

Introduction and welcome: evidence and guideline-based validation for factor Xa-based management of thrombosis-related disorders in cardiovascular medicine.

Speaker: Doctor S. Goldhaber (Boston, US)

Thumbnail

Practical dimensions and optimal deployment of oral factor Xa inhibitors in patients with non-valvular atrial fibrillation: the role of key clinical factors.

Speaker: Doctor J. Cox (Halifax, CA)

Thumbnail

Interactive case-based simulation focused on stroke prevention in atrial fibrillation: practical, real world management decisions using oral factor Xa inhibitors in patients with non-valvular atrial fibrillation.

Speaker: Professor R. De Caterina (Pisa, IT)

Thumbnail

Summary and take home messages: the foundation role of oral factor Xa inhibition for stroke prevention in atrial fibrillation and acute and extended management of venous thromboembolism.

Speaker: Doctor S. Goldhaber (Boston, US)

Thumbnail

Access the full session

Practical dimensions of novel anticoagulant-based prevention of stroke in atrial fibrillation and management of acute venous thromboembolism

Speakers: Professor A. Kakkar, Doctor S. Goldhaber, Doctor J. Cox, Professor R. De Caterina, Doctor S. Goldhaber
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk